Ocugen (OCGN) Current Leases (2018 - 2026)
Ocugen's (OCGN) quarterly Current Leases came in at $850000.0 in Q1 2026, up 15.49% YoY from $736000.0 in Q1 2025, and down 0.93% on a QoQ basis from $858000.0 in Q4 2025.
Analysis
Ocugen (OCGN) Current Leases (2018 - 2026) Analysis & Trends
Ocugen (OCGN) has 9 years of Current Leases data on file, last reported at $850000.0 in Q1 2026.
- Quarterly Current Leases rose 15.49% year-over-year to $850000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $850000.0 (up 15.49% YoY) and the FY2025 annual result came in at $858000.0, up 65.32% from the prior year.
- Current Leases fell to $850000.0 in Q1 2026, from $858000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $858000.0 in Q4 2025 to a low of $254000.0 in Q1 2022.
- A 5-year average of $579941.2 and a median of $526000.0 in 2023 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases soared 157.56% — and 2024, when it fell 12.36%.
- Tracing OCGN's Current Leases over 5 years: stood at $498000.0 in 2022, then climbed by 15.26% to $574000.0 in 2023, then dropped by 9.58% to $519000.0 in 2024, then soared by 65.32% to $858000.0 in 2025, then decreased by 0.93% to $850000.0 in 2026.
- The last three Current Leases figures came in at $850000.0 (Q1 2026), $858000.0 (Q4 2025), and $855000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Ocugen | 458.91 Mn | 358.81 Mn | - | 839,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 839,000.00 |
| Mar 31, 2026 | 850,000.00 |
| Dec 31, 2025 | 858,000.00 |
| Sep 30, 2025 | 855,000.00 |
| Jun 30, 2025 | 853,000.00 |
| Mar 31, 2025 | 736,000.00 |
| Dec 31, 2024 | 519,000.00 |
| Sep 30, 2024 | 477,000.00 |
| Jun 30, 2024 | 461,000.00 |
| Mar 31, 2024 | 589,000.00 |
| Dec 31, 2023 | 574,000.00 |
| Sep 30, 2023 | 540,000.00 |
| Jun 30, 2023 | 526,000.00 |
| Mar 31, 2023 | 512,000.00 |
| Dec 31, 2022 | 498,000.00 |
| Sep 30, 2022 | 443,000.00 |
| Jun 30, 2022 | 314,000.00 |
| Mar 31, 2022 | 254,000.00 |
| Dec 31, 2021 | 363,000.00 |
| Sep 30, 2021 | 172,000.00 |